This paper draws attention to an important adverse outcome in depression, the occurrence of residual symptoms after partial remission. Among patients with definite major depression followed every 3 months to remission and thereafter, residual symptoms reaching 8 or more on the Hamilton Depression Scale 17-item total were present in 32% (19) of the 60 who remitted below major depression by 15 months. The pattern was of mild but typical depressive symptoms. Residual symptoms were more common in subjects with more severe initial illness, but were not related to any other predictors, including longer prior illness, dysthymia, or lower dose of drug treatment during the illness episode. There were weak associations with personality that might hav...
Background Depression outcomes in research and clinical practice are commonly defined by the concept...
Objective: This study investigated the influence of incomplete recovery from first lifetime major de...
Of 3 1 6 patients with a major depressive disorder who were followed for between 6 months and 2 year...
Background. Residual depressive symptomatology constitutes a substantial risk for relapse in depress...
BACKGROUND: Residual depressive symptoms are generally documented as a risk factor for recurrence. I...
International audienceBACKGROUND: Residual depressive symptoms are generally documented as a risk fa...
Background. Residual depressive symptomatology constitutes a substantial risk for relapse in depress...
Despite the development of several effective treatments for depression, symptoms often persist in a ...
Notwithstanding major depressive disorder (MDD) is a recurring and chronic condition, relatively few...
This paper reports the course with respect to remission and relapse of a cohort of predominantly in-...
Background: There is increasing literature on the unsatisfactory degree of remission that current th...
BACKGROUND: Major depressive disorder (MDD) is characterized by high relapse/recurrence rates. Predi...
Rates of 50-70% of residual symptoms referring to subsyndromal manifestations between episodes that ...
Background Depression outcomes in research and clinical practice are commonly defined by the concept...
Background Depression outcomes in research and clinical practice are commonly defined by the concept...
Background Depression outcomes in research and clinical practice are commonly defined by the concept...
Objective: This study investigated the influence of incomplete recovery from first lifetime major de...
Of 3 1 6 patients with a major depressive disorder who were followed for between 6 months and 2 year...
Background. Residual depressive symptomatology constitutes a substantial risk for relapse in depress...
BACKGROUND: Residual depressive symptoms are generally documented as a risk factor for recurrence. I...
International audienceBACKGROUND: Residual depressive symptoms are generally documented as a risk fa...
Background. Residual depressive symptomatology constitutes a substantial risk for relapse in depress...
Despite the development of several effective treatments for depression, symptoms often persist in a ...
Notwithstanding major depressive disorder (MDD) is a recurring and chronic condition, relatively few...
This paper reports the course with respect to remission and relapse of a cohort of predominantly in-...
Background: There is increasing literature on the unsatisfactory degree of remission that current th...
BACKGROUND: Major depressive disorder (MDD) is characterized by high relapse/recurrence rates. Predi...
Rates of 50-70% of residual symptoms referring to subsyndromal manifestations between episodes that ...
Background Depression outcomes in research and clinical practice are commonly defined by the concept...
Background Depression outcomes in research and clinical practice are commonly defined by the concept...
Background Depression outcomes in research and clinical practice are commonly defined by the concept...
Objective: This study investigated the influence of incomplete recovery from first lifetime major de...
Of 3 1 6 patients with a major depressive disorder who were followed for between 6 months and 2 year...